Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v5-EN | |
---|---|---|
Language | French | English |
Date Updated | 2023-01-11 | 2023-01-11 |
Drug Identification Number | 02241497 | 02241497 |
Brand name | VENTOLIN HFA | VENTOLIN HFA |
Common or Proper name | salbutamol pressurised inhalation, suspension | salbutamol pressurised inhalation, suspension |
Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
Ingredients | SALBUTAMOL | SALBUTAMOL |
Strength(s) | 100MCG | 100MCG |
Dosage form(s) | METERED-DOSE AEROSOL | METERED-DOSE AEROSOL |
Route of administration | INHALATION INHALATION | INHALATION INHALATION |
Packaging size | 1x200 | 1x200 |
ATC code | R03AC | R03AC |
ATC description | ADRENERGICS, INHALANTS | ADRENERGICS, INHALANTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2022-12-01 | 2022-12-01 |
Estimated end date | 2023-02-01 | 2023-02-01 |
Actual end date | 2023-01-11 | 2023-01-11 |
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Inventory on allocation to support demand. | Inventory on allocation to support demand. |
Health Canada comments |